Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
135304-08-4
137132-70-8 | Naphtho[2,3-f]quinoxaline-7,12-dione,1,2,3,4-tetrahydro-8,11-dihydroxy-4-(2-hydroxyethyl)-6-[[2-[(2-hydroxyethyl)amino]ethyl]amino]- | AA007ZQN | MFCD09966043
133628-73-6 | H-Asp(amc)-oh | AA00809E | MFCD00236804
1210838-82-6 | 5-Bromo-3-ethynylpyridin-2-ylamine | AA0080MG | MFCD10566045
1213269-23-8 | N-(3-(5-Chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide | AA008177 | MFCD16621244
1133-42-2 | 1-Methyl-3,4-dihydro-1h-1,4-benzodiazepine-2,5-dione | AA0081VV | MFCD07492626
112391-34-1 | Benzoic acid, 2-iodosyl-4-nitro- | AA0082LG | MFCD00955925
108664-74-0 | 1-Propanone, 1-(4-methoxyphenyl)-3-(1H-1,2,4-triazol-1-yl)- | AA0083AR | MFCD10574946
106261-27-2 | 4-(Piperazin-1-yl)thieno[3,2-c]pyridine | AA0083YX | MFCD06796184
1074-02-8 | 2-(Methylsulfinyl)phenol | AA0084MP | MFCD00127350
103878-83-7 | Lazabemide hydrochloride | AA00856H | MFCD00878458
Journal: Bioorganic & medicinal chemistry letters20101101